Alterations of granulopoiesis following chemotherapy.
D000328:Adult; D000368:Aged; D001772:Blood Cell Count; D001853:Bone Marrow / Q000187:drug effects; D001854:Bone Marrow Cells; D002455:Cell Division / Q000187:drug effects; D002999:Clone Cells; D003561:Cytarabine / Q000009:adverse effects* / Q000627:therapeutic use; D004247:DNA / Q000096:biosynthesis; D004317:Doxorubicin / Q000627:therapeutic use; D005260:Female; D006023:Glycoproteins / Q000652:urine; D006410:Hematopoiesis / Q000187:drug effects*; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy; D008223:Lymphoma / Q000188:drug therapy; D008297:Male; D008938:Mitosis; D009113:Muramidase / Q000097:blood; D013866:Thioguanine / Q000009:adverse effects* / Q000627:therapeutic use; D013936:Thymidine / Q000378:metabolism; D014316:Tritium
D006023:Glycoproteins; D003561:Cytarabine; D014316:Tritium; D004317:Doxorubicin; D004247:DNA; D009113:Muramidase; D013866:Thioguanine; D013936:Thymidine